Complement activation in patients with diabetic nephropathy
Authors:
Open Access
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 45 (3) , 248-253
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritisBMC Nephrology, 2013
- Transcriptome Analysis of Human Diabetic Kidney DiseaseDiabetes, 2011
- High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetesNephrology Dialysis Transplantation, 2011
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- Modified low density lipoproteins differentially bind and activate the C1 complex of complementMolecular Immunology, 2007
- Alternative pathway activation of complement by cultured human proximal tubular epithelial cellsKidney International, 1994
- C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cellsClinical and Experimental Immunology, 1993
- Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes.BMJ, 1984